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Impaired fornix–hippocampus integrity is linked to peripheral
glutathione peroxidase in early psychosis
PS Baumann1,2, A Griffa3,4, M Fournier1, P Golay2,5, C Ferrari1, L Alameda1,2, M Cuenod1, J-P Thiran3,4, P Hagmann3,4,6, KQ Do1,6 and
P Conus2,6
Several lines of evidence implicate the fornix–hippocampus circuit in schizophrenia. In early-phase psychosis, this circuit has not
been extensively investigated and the underlying mechanisms affecting the circuit are unknown. The hippocampus and fornix are
vulnerable to oxidative stress at peripuberty in a glutathione (GSH)-deﬁcient animal model. The purposes of the current study were
to assess the integrity of the fornix–hippocampus circuit in early-psychosis patients (EP), and to study its relationship with
peripheral redox markers. Diffusion spectrum imaging and T1-weighted magnetic resonance imaging (MRI) were used to assess the
fornix and hippocampus in 42 EP patients compared with 42 gender- and age-matched healthy controls. Generalized fractional
anisotropy (gFA) and volumetric properties were used to measure fornix and hippocampal integrity, respectively. Correlation
analysis was used to quantify the relationship of gFA in the fornix and hippocampal volume, with blood GSH levels and glutathione
peroxidase (GPx) activity. Patients compared with controls exhibited lower gFA in the fornix as well as smaller volume in the
hippocampus. In EP, but not in controls, smaller hippocampal volume was associated with high GPx activity. Disruption of the
fornix–hippocampus circuit is already present in the early stages of psychosis. Higher blood GPx activity is associated with smaller
hippocampal volume, which may support a role of oxidative stress in disease mechanisms.
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INTRODUCTION
The fornix–hippocampus circuit1 is part of the classic Papez circuit,2
which has a crucial role in spatial memory, memory retrieval and
verbal memory,3,4 functions that are affected in schizophrenia.5
Studies investigating the hippocampus in schizophrenia high-
lighted volume loss,6–9 altered diffusion properties10–12 and
hypermetabolism13,14 at the neuroimaging level and decrease in
parvalbumin-immunoreactive γ-aminobutyric acid interneurons at
the microscopic level.14–16
Given its direct anatomical link with the hippocampus,
diffusion magnetic resonance imaging (MRI) studies also
focused on the fornix, a ﬁne compact, arch-shaped white matter
bundle connecting the hippocampus to the hypothalamus, and
various other cortical and subcortical structures including
mammillary bodies.17 These studies consistently showed a
decreased fractional anisotropy (FA) in the fornix in chronic
schizophrenia.4,18–22 Hippocampal volume (HV) correlates with the
mean diffusivity in the fornix in patients only, indicating important
structural relationship between these structures in disease.22
Interestingly, this tight relationship between the fornix and
hippocampus is also present in Alzheimer’s disease,1,23 hippo-
campal sclerosis in mesial temporal lobe epilepsy24–26 and
multiple sclerosis.27 Neuropathological characterization of the
fornix in schizophrenia showed no differences in ﬁber number but
higher ﬁber density in the fornix in male schizophrenia patients
compared with controls.28
The imbalance between oxidant and antioxidant systems is
emerging as an important pathophysiological hub in
schizophrenia29–33 and may contribute to the microstructural
alteration of the fornix–hippocampus circuit. Dysregulation of
glutathione (GSH) synthesis, the major non-protein cellular
antioxidant, is critically involved in a subgroup of schizophrenia
patients.30,34 The effect of redox dysregulation on the brain has
been studied in transgenic mice with a deletion of the modiﬁer
subunit of glutamate cysteine ligase (that is, Gclm-KO mice), which
leads to a 70% decrease in GSH brain levels and several
schizophrenia-related phenotypes.30,35 Recently, a longitudinal
14-Tesla diffusion tensor imaging study in Gclm-KO mice showed
a decrease in FA in the fornix.36 Diffusion tensor imaging
parameters were altered in peripubertal knockout mice and
remained altered in adulthood. Electrophysiological recordings in
the same model showed a signiﬁcant decrease in conduction
velocity in the ﬁmbria–fornix ﬁbers, providing a potential
functional basis of FA alterations. This study underlines the high
vulnerability of the fornix to oxidative stress induced by GSH
deﬁcit. Our recent report also supports the critical role of GSH
and redox regulation in the myelination processes and white
matter maturation.37,38 At the cellular level, research in the same
model showed that hippocampus fast-spiking parvalbumin
1Department of Psychiatry, Unit for Research in Schizophrenia, Center for Psychiatric Neuroscience, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital (CHUV),
University of Lausanne, Lausanne, Switzerland; 2Department of Psychiatry, Service of General Psychiatry, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital
(CHUV), Lausanne, Switzerland; 3Signal Processing Laboratory (LTS5), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; 4Department of Radiology, Lausanne
University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland and 5Service of Community Psychiatry, Department of Psychiatry, Lausanne University Hospital (CHUV),
Lausanne, Switzerland. Correspondence: Dr PS Baumann, Department of Psychiatry, Service of General Psychiatry, Centre Hospitalier Universitaire Vaudois, Lausanne University
Hospital (CHUV), University of Lausanne, Place Chauderon 18, Lausanne 1003, Switzerland or Professor KQ Do, Department of Psychiatry, Unit for Research in Schizophrenia,
Center for Psychiatric Neuroscience, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital (CHUV), University of Lausanne, Prilly-Lausanne 1008, Switzerland.
E-mail: philipp.baumann@chuv.ch or kim.do@chuv.ch
6These authors contributed equally to this work.
Received 5 December 2015; revised 17 March 2016; accepted 15 April 2016
Citation: Transl Psychiatry (2016) 6, e859; doi:10.1038/tp.2016.117
www.nature.com/tp
γ-aminobutyric acid interneurons and their synchronization are
also impaired, all features known to be affected in schizophrenia.39
In summary, preclinical research indicates that redox imbalance
affects the fornix and hippocampus, with relevance to schizo-
phrenia. The critical vulnerability of the fornices and hippocampi
to oxidative stress during development fueled new hypotheses.
Fornix alterations around puberty in Gclm-KO mice would predict
potential white matter anomalies in the early phase of psychosis
as well as a link with GSH/redox systems. Capturing the peripheral
redox balance is not straightforward, and studies on the various
antioxidant systems in the peripheral tissue of schizophrenia
patients showed large discrepancies between studies,31,40,41
which may be due to different stages of disease (acute versus
chronic or active versus remission phase), differences in analytical
methodologies, testing materials (blood cells versus plasma or
serum), exposure to medication, lifestyle (for example, smoking) or
dietary intake.31,41 Glutathione peroxidases (GPx) are an important
selenium-dependent antioxidant enzyme family that eliminates
hydrogen and lipid peroxides by oxidizing GSH and are thus an
effective protection against cellular injuries. The oxidized GSH is
then reduced back by the GSH reductase. Recent studies showed
reduced FA in the fornix in ﬁrst-episode psychosis patients;42,43
however, its relationship to HV and peripheral redox markers in
the early phase of psychosis has, to the best of our knowledge,
never been tested before.
From a reverse translational train of thought, from models
to patients, we thus aim to test (1) the presence of white
matter alterations in the fornix and its relationship with hippo-
campus integrity in early-psychosis (EP) patients thanks to
diffusion spectrum imaging (DSI) and volumetry. (2) The correla-
tion between structural integrity in the fornix–hippocampus
circuit and peripheral GPx activity and GSH levels.
MATERIALS AND METHODS
Subjects
EP patients, having met threshold criteria for psychosis, as deﬁned by the
‘Psychosis threshold’ subscale of the Comprehensive Assessment of At Risk
Mental States44 were recruited from the TIPP Program (Treatment and
Early Intervention in Psychosis Program, University Hospital, Lausanne,
Switzerland).45 This EP program offers 3 years of treatment to patients
aged 18–35 years. Diagnoses were assessed according to the Diagnostic
and Statistical Manual of Mental Disorders criteria. Healthy controls,
recruited from similar geographic and sociodemographic areas through
advertisement, were assessed by the Diagnostic Interview for Genetic
Studies46 and matched on gender, age and handedness. Major mood,
psychotic or substance-use disorder as well as having a ﬁrst-degree relative
with a psychotic disorder were exclusion criteria for controls. Neurological
disorders and severe head trauma were exclusion criteria for all subjects. In
both patients and controls, cigarette smoking and cannabis status were
recorded (user or non-user) as well as weight and height in order to
calculate body mass index (BMI; kg/m2). For patients, daily cigarette
consumptions and cannabis use assessed with the Case Manager Rating
Scale (CMRS; adapted from Drake et al.;47 1 = non, 2 =mild, 3 =moderate,
4 = severe and 5= extremely severe) were also available. All assessments
(MRI, blood and clinical) were performed at the same time point. Symptomatic
severity was assessed with the Positive and Negative Syndrome Scale
(PANSS) administered by a trained psychologist. Antipsychotic doses at the
time of the study were converted to chlorpromazine equivalents (CPZ
equivalents in mg)48 for each patient. Informed written consent in
accordance with our institutional guidelines (protocol approved by the
Ethic Committee of Lausanne University) was obtained for all the subjects.
MRI acquisition and analysis
MRI acquisition. MRI sessions were performed on a 3-Tesla scanner
(Magnetom TrioTim, Siemens Medical Solutions, Erlangen, Germany)
equipped with a 32-channel head coil. Each scanning session included
a magnetization-prepared rapid acquisition gradient echo (MPRAGE)
T1-weighted sequence with 1-mm in-plane resolution and 1.2-mm slice
thickness, covering 240× 257× 160 voxels. The repetition (TR), echo (TE)
and inversion (TI) times were, respectively, 2300, 2.98 and 900 ms. The DSI
sequence included 128 diffusion-weighted images with a maximum b-value
of 8000 s mm−2 and one b0 reference image. The acquisition volume was
made of 96× 96× 34 voxels with 2.2 × 2.2 × 3 mm resolution. TR and TE
were, respectively, 6800 and 144 ms.
MRI analysis. All images were visually inspected for artifacts or structural
abnormalities. Diffusion and T1-weighted MRI data were processed using
the Connectome Mapping Toolkit (http://www.cmtk.org/).49–51 MPRAGE
volumes were segmented into white matter, gray matter and cerebrospinal
ﬂuid compartments, and were linearly registered to the b0 volume. Gray
matter and subcortical structures (notably the hippocampus) were
segmented using the FreeSurfer software (version 1.313.2.6; https://
surfer.nmr.mgh.harvard.edu/).52 DSI data were reconstructed according
to Weeden et al.,53 allowing to estimate multiple diffusion directions per
voxel. Deterministic streamline tractography54 was performed on DSI-
reconstructed data.
Generalized FA (gFA), calculated as described by Tuch et al.,55 is similar
to the concept of FA and describes the local degree of anisotropy of a
diffusion process while compensating for multiple orientations within
single voxels.
The fornix segmentation method was developed for the current study
using the Trackvis software (http://trackvis.org).56 The only manual
procedure was the placement of a sphere of diameter 10 mm in the body
of the fornix, which was performed on the MPRAGE by the investigator
(PSB), blind to diagnosis. Bilateral hippocampi were selected according to
FreeSurfer segmentation.52 Then, ﬁber tracts connecting the left and right
hippocampi to the sphere were selected. Length thresholding (streamlines
longer than 80 mm were discarded) allowed an exquisite delineation of
the fornix (columns, body and crura; Figure 1). All parameters (sphere size
and ﬁber length thresholding) were set identically for all subjects. Then,
average gFA was extracted along the left and right fornix.
HV was obtained from the FreeSurfer software segmentation. HV of each
individual subject was corrected for intracranial volume (ICV) by
computing the ratio (HV in mm3/ICV in mm3).
Peripheral GPx activity and GSH levels
Blood was collected by venipuncture between 0700 and 0830 hours under
restricted activity conditions and fasting from the previous midnight. Blood
cells were prepared as in Gysin et al.57 Vacutainer tubes coated with Li-
heparinate (Becton Dickinson, Franklin Lakes, NJ, USA), previously placed
on ice, were used to collect 18–20 ml blood. An aliquot of whole blood was
sampled and frozen at − 80 °C until analysis of GSH content. The rest of the
blood was centrifuged at 3000 g, 5 min, 4 °C; the pellet, corresponding to
blood cells, was washed two times with 0.9% NaCl and was frozen at − 80 °
C until analysis. All manipulations were performed rapidly with cooling to
avoid artefactual oxidation of thiol compounds.
The activity of GPx was determined according to Günzler et al.58 In brief,
8 µl of hemolyzed blood was incubated in a phosphate buffer solution
(100 mM, pH7.5) containing EDTA (0.6 mM), oxidized GSH (3 mM), NADPH
(0.25 mM), GSH reductase (0.84 U ml− 1; Sigma-Aldrich, St. Louis, MO, USA)
and Tert-butyl hydroperoxide (0.8 mM; Sigma-Aldrich). The GPx activity
was determined as a function of the decrease in NADPH measured at
340 nm and normalized to hemoglobin content (for blood).
The GSH content was measured in 45 µL of whole blood and normalized
to blood volume. GSH levels were quantiﬁed by a colorimetric approach
using a diagnostic kit (Glutathione Assay kit, Calbiochem, San Diego, CA,
USA).57
Statistical analysis
Statistical analyses were performed with SPSS (SPSS, Chicago, IL, USA).
Differences between patients and controls in handedness, gender, and
smoking and cannabis status (users versus non users) were assessed with
Χ2-test. Differences in age and years of parental education were assessed
with t-test. Group differences in GPx activity and GSH levels were tested
with Mann–Whitney U-test because of skewness of the distribution of the
control group. Outcome measures for brain metrics were hippocampus
volume and gFA in the fornix. Group differences in fornix gFA and
hippocampus volume were tested with analysis of covariance, with group
(patients versus controls) as a between-subject factor and hemisphere as a
within-subject factor, and gender and age as covariates. Assumptions of
homogeneity of variance between groups were checked through Levene's
test. Our sample size was comparable to similar studies and power
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estimation indicated that it was sufﬁcient to detect effects in the medium
range according to Cohen. Correlation analyses were tested with Pearson’s
correlation coefﬁcient. Pearson partial correlations were used when
correcting for lifestyle factors (BMI, consumption of cigarettes and
cannabis) and CPZ equivalents. Correlating brain metrics (hippocampus
volume and gFA in the fornix) with redox markers (GSH levels and GPx
activity) generated four comparisons, and thus the alpha level to detect
signiﬁcant correlations was set to 0.01. For intra-rater reliability regarding
the fornix, six subjects randomly selected were replicated two times by the
investigator. Intra-rater correlations for the fornix reached 0.99 for left and
right fornix, indicating excellent reliability.
RESULTS
Subject characteristics
There were no statistical differences in age, gender, handedness
or parental education between the EP and healthy control groups
(Table 1), indicating that patients and controls were well matched
for these criteria. There was no signiﬁcant difference in BMI
between patients and controls. However there were more smokers
and cannabis users in the patient group. Of the total patients, 69%
were not using cannabis, whereas 16.7% were mild users and
Table 1. Subjects' characteristics
Early psychosis patients (N=42) Control subjects (N= 42) P-value
Age, mean± s.d. 25.0± 5.4 25.3± 5.3 NSa
Gender, M/F 28/14 29/13 NSb
Handedness right/left/ambidextrous 36/4/2 35/6/1 NSb
Education of parents (years) 13.2± 4.1 14.1± 4.7 NSa
GPx activity (µmol/min/g of Hb)c 20.8± 6.6f 26.4± 13.6e NSd
GSH (µmol/ml)c 0.79± 0.3 0.69± 0.3 NSd
Cigarettes users/non-user 24/18 1/36 Po0.05b
Cannabis user/non-user 13/29 1/38 Po0.05b
BMI, mean± s.d. 23.7 22.5e NSa
Duration of illness, days 630.7± 425.9 — —
CPZ eq., mean± s.d. 340.6± 223.6 — —
PANSS positive, mean± s.d. 13.6± 4.6 — —
PANSS negative, mean± s.d. 15.6± 5.7 — —
PANSS general, mean± s.d. 33.6± 8.9 — —
Abbreviations: Age in years; BMI, body mass index (kg/m2); CPZ eq., antipsychotic medication converted to chlorpromazine equivalent, in mg; GPx, glutathione
peroxidase; GSH, glutathione; Hb, hemoglobin; NS, nonsigniﬁcant; PANSS, Positive and Negative Syndrome Scale: positive symptom score, negative symptom
score, general symptom score. at-test. bΧ2-test. cGPx and GSH measurements were conducted on blood and normalized, respectively, to Hb and blood volume.
dMann–Whitney U-test. eData missing for two subjects. fData missing for one subject.
Figure 1. Fornix segmentation method. (a) Placement of a sphere (in yellow) in the body of the fornix on T1 scan (sagittal view). (b) Selection
of left (pink) and right (blue) hippocampi. (c) The fornix was deﬁned as ﬁbers connecting the sphere and the left and right hippocampi. (d)
Lateral view of the fornix bundle (in green). Posterior part of the brain is on the right side of each ﬁgure.
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14.3% were moderate users. At 18 months of follow-up in the TIPP
program, diagnostic repartition was as follows: 57% schizophrenia
(n= 24), 16.7% brief psychotic episode (n= 7), 11.9% schizoaffec-
tive disorder (n = 5), 4.8% bipolar disorder (n = 2), 4.8% major
depression with psychotic features (n= 2), 2.4% schizophreniform
disorder (n= 1) and 2.4% psychosis not otherwise speciﬁed
(n= 1). At the time of this study, 39 of the 42 patients were
on antipsychotic medication with an average medication of
340.6 ± 223.6 mg CPZ equivalents (Table 1). The mean duration of
illness was 340.6 days (s.d. ± 223.6).
MRI ﬁndings
Alteration of fornix and hippocampus metrics in EP patients. Tests
of between subjects effects revealed a signiﬁcant group difference
in corrected HV (HV / ICV) with EP subjects exhibiting smaller
volume than healthy controls (F(1,80) = 6.79, P = 0.011; Figure 2).
There was no main hemisphere effect but a group by hemisphere
interaction (F(1,80) = 5.98, P= 0.017) indicating that differences
between groups were larger in the left than in the right
hemisphere. Left hippocampus in patients were smaller than that
in controls (P= 0.002), whereas right hippocampus difference did
not reach statistical signiﬁcance.
The same analysis of covariance model but comparing absolute
hippocampus volume (that is, not normalized by ICV) also
revealed signiﬁcant differences between hemispheres (F
(1,80) = 12.352, P= 0.001); both left and right hippocampi were
signiﬁcantly smaller in EP patients than in controls (P= 0.0002 and
P= 0.005).
Analysis of covariance of fornix gFA showed a signiﬁcant group
effect (F(1,78) = 4.482, P = 0.037) with lower gFA in EP patients
than in controls (Figure 3). There was neither hemisphere effect
nor group by hemisphere interaction.
There were no signiﬁcant correlations between CPZ equivalents,
number of daily cigarettes, cannabis use (assessed by CMRS) and
fornix gFA or absolute hippocampal volume.
Correlation between hippocampus and fornix metrics. We used
correlation analyses to test the interdependence of fornix and
hippocampus integrity. Overall, gFA in the fornix correlated with
absolute hippocampus volume (r = 0.287; P= 0.009). When groups
were studied separately, in controls gFA in the fornix did not
correlate with hippocampus volume (r= 0.086; P = 0.593). How-
ever, these two metrics correlated in patients (r= 0.388; P= 0.012)
even when corrected for CPZ equivalents and lifestyle factors
(cigarette smoking, cannabis and BMI; r= 0.387; P = 0.018).
Correlation between hippocampus and fornix integrity and
peripheral redox markers
There were no signiﬁcant differences between patients and
controls in blood GPx activities or GSH levels (Table 1;
Supplementary Figure 1).
In order to test the relationship between fornix and hippocam-
pus structures and GSH-related markers, we correlated imaging
metrics with GPx activity and GSH levels. In patients but not in
controls, smaller hippocampus volume was associated with higher
GPx activity (r= 0.412; P = 0.007; Figure 4). In patients, when
corrected for medication (CPZ equivalents) and lifestyle factors
(cigarette smoking, cannabis and BMI), correlation between
hippocampus volume and GPx activity remained signiﬁcant
(r=− 0.415; P = 0.012). GPx activity did not correlate with gFA in
patients or controls. GSH did not correlate with any brain metrics
in patients or controls.
DISCUSSION
We characterized fornix and hippocampus integrity in EP patients
and observed altered diffusion and volumetric properties in the
fornix and hippocampus, respectively. We applied for the ﬁrst time
in EP a DSI sequence characterized by strong diffusion weighting.
We also provided new evidence that loss of integrity of this circuit
is associated with an increased peripheral oxidative status. This
observation involves the fornix–hippocampus circuit early in the
course of psychosis and, although the detected associations do
not imply causality, we provide a plausible hypothesis of the
negative impact of oxidative stress on the fornix–hippocampus
circuit.
This study was initiated in a reverse translational approach, from
GSH-deﬁcient mouse model to EP patients, following the
observations of speciﬁc structural and functional alterations in
the hippocampus39 and fornix36 in Gclm-KO mice.
We used volumetric and diffusion MRI to study the integrity of
the fornix–hippocampus circuit.
The DSI sequence, characterized by multiple b-values along
several diffusion directions, is more sensitive to white matter slow
diffusion compartment59–62 (that is, intra-axonal diffusion) than
classical diffusion tensor imaging and was only recently applied to
schizophrenia.63 Patients exhibited decreased gFA in the fornix,
which is consistent with two recent studies in ﬁrst-episode
patients.42,43 This is so far the largest cohort showing impaired
fornix integrity in the early phase of psychosis. Loss of integrity in
the fornix in schizophrenia is a robust ﬁnding,4,18–22,64 although
with mixed results in childhood and adolescent schizophrenia.65,66
Fornix integrity deﬁcit parallels the report of loss of HV in
chronic schizophrenia, which is already present in the early
phase of psychosis.8 In our study, the hippocampus of patients
also exhibited volume loss, especially on the left side, which
is in line with the ﬁndings showing smaller left than right
hippocampus in patients8 and bilateral involvement only in
patients with established schizophrenia.9 Finally, volume loss in
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Figure 2. The mean corrected hippocampus volume for controls and
early-psychosis (EP) patients. *Po0.05. Error bars denote± s.d. for
each group.
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Figure 3. The mean generalized fractional anisotropy (gFA) in the
fornix for controls and early-psychosis (EP) patients. *Po0.05. Error
bars denote ±s.d. for each group.
GPx and fornix–hippocampus circuit in psychosis
PS Baumann et al
4
Translational Psychiatry (2016), 1 – 8
the hippocampus correlated with loss in integrity in the fornix
(gFA), extending ﬁndings from chronic schizophrenia to EP.22,67
Taken together, these results indicate that microstructural
abnormalities in the fornix are present in the early phase of
psychosis and are associated with abnormalities in the hippo-
campus. Given its early involvement in the disease process, fornix
pathology may be an early marker of disease rather than a
consequence of chronicity.
There were more cigarette smokers and cannabis users among
patients, which may bias our ﬁndings. We found however no
signiﬁcant correlations between cigarette smoking or cannabis
use and brain metrics in EP patients. Further, in the current
sample, more than 2/3 of the sample was not using cannabis and
there were no severe or extremely severe cannabis users.
There was no difference between patients and controls in the
mean GPx activity, which is in line with a recent meta-analysis by
Flatow et al.,31 showing no change in GPx activity in the early
phase, but a decrease in GPx in chronic inpatients and during
acute relapse.31 In the EP cohort of the current study, we showed
for the ﬁrst time that small HV was associated with high GPx
activity (even when controlling for medication and lifestyle factors
such as smoking, cannabis and BMI). However, although there was
a loss of integrity in the fornix in patients, gFA in the fornix did not
correlate with GPx enzymatic activities. This is an unexpected
ﬁnding, which deserves further consideration. The gclm-KO mice
exhibit a decrease of 70% in brain GSH levels, which alters the
hippocampus29 as well as the fornix36 integrity and function. It is
worthwhile mentioning that this animal model may represent an
extreme condition in terms of oxidative stress compared with EP
patients. We can thus hypothesize that the hippocampus may be
more sensitive to oxidative stress than the fornix bundle, which
may partly explain the lack of correlation.
Recent work from our group68,69 showed that in male healthy
controls brain GSH levels (as assessed by magnetic resonance
spectroscopy) were positively correlated with blood GPx activity,
whereas in male patients this correlation was negative. This is
coherent with the idea that high blood GPx activity is associated
with low brain GSH levels in patients and that high GPx activity
reﬂects a high central oxidative state.
It is well established that oxidative stress and reactive oxygen
species (ROS) generation (probably from genetic and environ-
mental risks) lead on one hand to GPx activation and on the other
to the activation of the transcription factor NRF2, which in turn
upregulate the antioxidant defense system, including GPx.70,71
On the basis of our ﬁndings as well as the review by Flatow
et al.,31 it is possible that in the early phase of the disease GPx
activity may still be upregulated in response to oxidative stress. In
contrast, in the chronic phase this adaptative response is impaired,
leading to a vicious circle, as inactivation of GPx causes additional
oxidative stress.72 This view is compatible with the fact that
chronic patients with lower blood-cell GPx activity have higher
brain atrophy (measured by computed tomography).73
Taken together, these ﬁndings indicate that in patients blood-
cell GPx activity may represent a potential surrogate marker of the
central redox status at least in the early phase of the disease.
Given the absence of differences in GPx activity between patients
and controls, our ﬁndings may be especially relevant to a
subgroup of patients with excess of ROS (for example, from
environmental impacts) or/and with antioxidant defense deﬁ-
ciency (for example, ‘high-risk’ polymorphism of GCLC, the gene
coding for the catalytic subunit of glutamate cysteine ligase).
It is plausible that redox dysregulation/oxidative stress may
affect the integrity of the hippocampus, as observed in animal
models.39 Hippocampal atrophy in schizophrenia has been linked
to neuronal atrophy and loss of neuropil,74 which may be a
consequence of redox dysregulation, although other factors such
as inﬂammation and hypothalamic–pituitary–adrenal axis dysfunc-
tion have also been shown to be important for hippocampus
integrity.75 Much more remains to be learned to fully appreciate
the relevance and signiﬁcance of blood GPx activity along
the various stages of the disease. The fact that low level of
selenium is a risk factor for schizophrenia76 supports the need for
further studies on GPx in patients. Indeed, GPx are selenium-
containing enzymes whose activities depend on this essential
micronutrient.41,76
GPx activity did not correlate with hippocampus volume in
healthy controls, a ﬁnding that deserves further comments. It is
plausible that GPx activity is not a limiting factor as antioxidant
defense in the healthy individual as this system involves many
factors others than GPx (including superoxide dismutase, catalase,
thioredoxin, sulforedoxin and so on). In patients, however, the
correlation suggests that this system may become critically
limiting.30 Blood GSH concentration was not different between
patients and controls. We found no association between
peripheral GSH levels and hippocampus volume.
Given the lack of correlation of fornix integrity with GPx
enzymatic activities and its association with hippocampus
volumetric reductions, it may be argued that the hippocampus
pathology is primary and loss of fornix integrity a functional
consequence of hippocampal atrophy.22 Indeed, some interde-
pendence between fornix and hippocampus is expected as the
main output of the hippocampus, that is, CA1 and subiculum,
conveys ﬁbers via the ﬁmbria and the fornix to the mammillary
body.1 Further, Schobel et al.13 showed that ‘at-risk patients’
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Figure 4. Correlations of hippocampal volume (mm3) and glutathione peroxidase (GPx) activity (µmol of GSH/min/g of hemoglobin) in
(a) controls (n= 40) and (b) early-psychosis (EP) patients (n= 41). Note that in patients larger hippocampal volume is associated with lower GPx
activity (tested with Pearson’s correlation). This relationship is absent in controls. Removing the three outliers with high GPx values (450) in
the control group did not change our conclusions. GSH, glutathione.
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exhibited hypermetabolism beginning in CA1 and spreading to
subiculum after psychosis onset. In the same study, hippocampal
atrophy appeared during transition to psychosis. In this regard, it
is interesting to note that the fornix connects the hippocampus to
the mammillary bodies, which are both structures exhibiting
decrease in PV interneurons typically vulnerable to oxidative
stress.15,77 However, others have argued that CA1 is relatively
spared in schizophrenia at the neuropathological level compared
with other subﬁelds,74 and hippocampal atrophy may thus not
fully explain fornix alterations. Further, fornix pathology is
involved early in schizophrenia,42,43 although it is not known
whether it is already affected in ‘at-risk patients’. Further investiga-
tions will be necessary to evaluate whether and to which extent
redox imbalance affects directly fornix integrity in the early phase
of psychosis.
Some limitations in our study must be taken into consideration.
First, regarding antioxidant defense mechanisms, we assessed GPx
and GSH, although other enzymatic and non-enzymatic antiox-
idants may be important as well. Second, we did not measure ROS,
which are reactive and unstable molecules. Sources of ROS are
multiple and include known environmental risk factors for
schizophrenia but also genetic factors, dopamine metabolism,
antipsychotics and inﬂammation.30,78 In addition, mitochondria
electron transport chain leakage is an important source of ROS
and previous work indicated mitochondrial impairment in
schizophrenia.78–81 Oxidation and peroxidation of macromole-
cules (lipids, proteins and DNA; that is, consequence of excessive
oxidative stress) have also been repeatedly reported in
patients30,31,82 and may constitute an alternative to ROS assess-
ment. Some additional caveats must also be considered. We found
a decrease in gFA, a metric that can be modulated by myelin
integrity but also other factors such as axonal size and volume of
water surrounding axons,83 and we can only speculate about
which factor is the most implicated. Second, our patient sample
was not neuroleptic-naive. However, we controlled for CPZ
equivalents, which did not correlate with gFA or HV in patients.
Further, our sample is in the early phase of psychosis and was not
exposed to chronic antipsychotic treatment. It is thus unlikely that
our ﬁndings are fully explained by antipsychotic medication.
CONCLUSION
Our study shows that GPx activity is a peripheral correlate of
hippocampus integrity in EP patients, which suggests a role for
oxidative stress in the disease mechanism. Further translational
research is needed to determine to which degree peripheral
markers reﬂect central mechanisms in order to establish clinically
useful peripheral biomarkers. In addition, the identiﬁcation of
oxidative stress as a potential contributing mechanism to
psychosis suggests its implication as a mediating factor between
environmental stressors (such as trauma, for example, Alameda
et al.84) and development of such disorders. These possible
mechanisms should be explored in future work. Finally, the
investigation of fornix–hippocampus integrity in the prodromal
phase of psychosis is warranted, considering that it may be useful
as an early marker of risk.
CONFLICT OF INTEREST
The authors declare no conﬂict of interest.
ACKNOWLEDGMENTS
We are grateful for technical assistance to Hélène Moser and Adeline Cottier. We
thank all patients and volunteers for their enduring participation. This work was
supported by the Swiss National Science Foundation (320030-130090 to PH,
320030_122419 to PC and KQD), National Center of Competence in Research (NCCR)
’SYNAPSY - The Synaptic Bases of Mental Diseases‘ ﬁnanced by the Swiss National
Science Foundation (no. 51AU40_125759) and the foundations Avina, Damm-Etienne
and Alamaya. PH was ﬁnancially supported by Leenaards Foundation.
REFERENCES
1 Fletcher E, Raman M, Huebner P, Liu A, Mungas D, Carmichael O et al. Loss of
fornix white matter volume as a predictor of cognitive impairment in cognitively
normal elderly individuals. JAMA Neurol 2013; 70: 1389–1395.
2 Papez J. A proposed mechanism of emotion. Arch Neurol Psychiatry 1937; 38:
725–733.
3 Thomas AG, Koumellis P, Dineen RA. The fornix in health and disease: an
imaging review. Radiographics 2011; 31: 1107–1121.
4 Fitzsimmons J, Kubicki M, Smith K, Bushell G, Estepar RSJ, Westin C-F et al. Dif-
fusion tractography of the fornix in schizophrenia. Schizophr Res 2009; 107: 39–46.
5 Cirillo Ma, Seidman LJ. Verbal declarative memory dysfunction in schizophrenia:
from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev
2003; 13: 43–77.
6 Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA. Reduced
temporal limbic structure volumes on magnetic resonance images in ﬁrst episode
schizophrenia. Psychiatry Res 1990; 35: 1–13.
7 Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction
in schizophrenia as assessed by magnetic resonance imaging. Arch Gen Psychiatry
1998; 55: 433–440.
8 Adriano F, Caltagirone C, Spalletta G. Hippocampal volume reduction in ﬁrst-
episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist
2012; 18: 180–200.
9 Velakoulis D, Wood SJ, Wong MTH, McGorry PD, Yung A, Phillips L et al. Hippo-
campal and amygdala volumes according to psychosis stage and diagnosis: a
magnetic resonance imaging study of chronic schizophrenia, ﬁrst-episode psy-
chosis, and ultra-high-risk individuals. Arch Gen Psychiatry 2006; 63: 139–149.
10 White T, Kendi AT, Lehericy S, Kendi M, Karatekin C, Guimaraes A et al. Disruption
of hippocampal connectivity in children and adolescents with schizophrenia--a
voxel-based diffusion tensor imaging study. Schizophr Res 2007; 90: 302–307.
11 Spoletini I, Cherubini A, Banﬁ G, Rubino IA, Peran P, Caltagirone C et al. Hippo-
campi, thalami, and accumbens microstructural damage in schizophrenia: a
volumetry, diffusivity, and neuropsychological study. Schizophr Bull 2011; 37:
118–130.
12 Kalus P, Buri CAC, Slotboom J, Gralla J, Remonda L, Dierks T et al. Volumetry and
diffusion tensor imaging of hippocampal subregions in schizophrenia. Neurore-
port 2004; 15: 867–871.
13 Schobel SA, Chaudhury NH, Khan UA, Paniagua B, Styner MA, Asllani I et al.
Imaging patients with psychosis and a mouse model establishes a spreading
pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron
2013; 78: 81–93.
14 Heckers S, Konradi C. Hippocampal pathology in schizophrenia. In: Swerdlow
NR (ed). Current Topics in Behavioral Neurosciences Series Editors. Springer. Berlin,
Heidelberg, 2010, pp 529–553.
15 Zhang ZJ, Reynolds GP. A selective decrease in the relative density of parvalbu-
min- immunoreactive neurons in the hippocampus in schizophrenia. Schizophr
Res 2002; 55: 1–10.
16 Lewis DA. Inhibitory neurons in human cortical circuits: substrate for cognitive
dysfunction in schizophrenia. Curr Opin Neurobiol 2014; 26C: 22–26.
17 Nieuwenhuys R, Voogd J, van Huijzen C. The Human Central Nervous System: a
Synopsis and Atlas [Hardcover]. 4th edn, Springer: Steinkopff, 2007.
18 Takei K, Yamasue H, Abe O, Yamada H, Inoue H, Suga M et al. Disrupted integrity
of the fornix is associated with impaired memory organization in schizophrenia.
Schizophr Res 2008; 103: 52–61.
19 Zhou Y, Shu N, Liu Y, Song M, Hao Y, Liu H et al. Altered resting-state functional
connectivity and anatomical connectivity of hippocampus in schizophrenia.
Schizophr Res 2008; 100: 120–132.
20 Abdul-Rahman MF, Qiu A, Sim K. Regionally speciﬁc white matter disruptions of
fornix and cingulum in schizophrenia. PLoS One 2011; 6: e18652.
21 Qiu A, Tuan TA, Woon PS, Abdul-Rahman MF, Graham S, Sim K. Hippocampal-
cortical structural connectivity disruptions in schizophrenia: an integrated per-
spective from hippocampal shape, cortical thickness, and integrity of white
matter bundles. Neuroimage 2010; 52: 1181–1189.
22 Kuroki N, Kubicki M, Nestor PG, Salisbury DF, Park HJ, Levitt JJ et al. Fornix
integrity and hippocampal volume in male schizophrenic patients. Biol Psychiatry
2006; 60: 22–31.
23 Lee DY, Fletcher E, Carmichael OT, Singh B, Mungas D, Reed B et al. Sub-regional
hippocampal injury is associated with fornix degeneration in Alzheimer’s disease.
Front Aging Neurosci 2012; 4: 1.
24 Hori A. Unilateral volume loss of the fornix in patients with seizures caused by
ipsilateral hippocampal sclerosis. AJR Am J Roentgenol 1995; 164: 1304.
GPx and fornix–hippocampus circuit in psychosis
PS Baumann et al
6
Translational Psychiatry (2016), 1 – 8
25 Kim JH, Tien RD, Felsberg GJ, Osumi AK, Lee N. Clinical signiﬁcance of asymmetry
of the fornix and mamillary body on MR in hippocampal sclerosis. AJNR Am J
Neuroradiol 1995; 16: 509–515.
26 Oikawa H, Sasaki M, Tamakawa Y, Kamei A. The circuit of Papez in mesial temporal
sclerosis: MRI. Neuroradiology 2001; 43: 205–210.
27 Koenig Ka, Sakaie KE, Lowe MJ, Lin J, Stone L, Bermel Ra et al. Hippocampal
volume is related to cognitive decline and fornicial diffusion measures in multiple
sclerosis. Magn Reson Imaging 2014; 32: 354–358.
28 Chance Sa, Highley JR, Esiri MM, Crow TJ. Fiber content of the fornix in schizo-
phrenia: lack of evidence for a primary limbic encephalopathy. Am J Psychiatry
1999; 156: 1720–1724.
29 Steullet P, Cabungcal JH, Monin A, Dwir D, Donnell OP, Cuenod M et al. Redox
dysregulation, neuroinﬂammation, and NMDA receptor hypofunction: a ‘central
hub’ in schizophrenia pathophysiology? Schizophr Res 2014 pii: S0920–9964(14)
00313–2 (Epub ahead of print).
30 Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. Redox dysregulation, neu-
rodevelopment, and schizophrenia. Curr Opin Neurobiol 2009; 19: 220–230.
31 Flatow J, Buckley P, Miller BJ. Meta-analysis of oxidative stress in schizophrenia.
Biol Psychiatry 2013; 74: 400–409.
32 O’Donnell P, Do KQ, Arango C. Oxidative / nitrosative stress in psychiatric dis-
orders : are we there yet ? Schizophr Bull 2014; 40: 960–962.
33 Hardingham G, Do KQ. Linking early-life NMDAR hypofunction and oxidative
stress in schizophrenia pathogenesis. Nat Rev Neurosci 2015; 17: 125–134.
34 Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P et al. Impaired glu-
tathione synthesis in schizophrenia: convergent genetic and functional evidence.
Proc Natl Acad Sci USA 2007; 104: 16621–16626.
35 Kulak A, Cuenod M, Do KQ. Behavioral phenotyping of glutathione-deﬁcient mice:
relevance to schizophrenia and bipolar disorder. Behav Brain Res 2012; 226: 563–570.
36 Corcoba A, Steullet P, Duarte JMN, Van de Looij Y, Monin A, Cuenod M et al.
Glutathione deﬁcit affects the integrity and function of the ﬁmbria/fornix and
anterior commissure in mice: relevance for schizophrenia. Int J Neuropsycho-
pharmacol 2015; 19, pyv110.
37 Monin A, Baumann PS, Griffa A, Xin L, Mekle R, Fournier M et al. Glutathione deﬁcit
impairs myelin maturation: relevance for white matter integrity in schizophrenia
patients. Mol Psychiatry 2014; 20: 827–838.
38 Monin A, Fournier M, Baumann PS, Cuenod M, Do KQ. Role of redox dysregulation
in white matter anomalies associated with schizophrenia. In: Pletnikov Mikhail V.,
Waddington John L. (eds). Modeling the Psychopathological Dimensions of
Schizophrenia: From Molecules to Behavior. Handbook of Behavioral Neuroscience
23, Academic Press: pp 481-500
39 Steullet P, Cabungcal J-H, Kulak A, Kraftsik R, Chen Y, Dalton TP et al. Redox
dysregulation affects the ventral but not dorsal hippocampus: impairment of
parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci 2010;
30: 2547–2558.
40 Yao JK, Keshavan MS. Antioxidants, redox signaling, and pathophysiology in
schizophrenia: an integrative view. Antioxid Redox Signal 2011; 15: 2011–2035.
41 Do K, Bovet P, Cabungcal J, Conus P, Gysin R, Lavoie S et al. Redox dysregulation
in schizophrenia: genetic susceptibility and pathophysiological mechanismsIn: A
Lajtha (ed)Handbook of Neurochemistry and Molecular Neurobiology, 3rd edn.
Springer Science+Business Media: New York, 2009, pp 286–311.
42 Luck D, Malla AK, Joober R, Lepage M. Disrupted integrity of the fornix in ﬁrst-
episode schizophrenia. Schizophr Res 2010; 119: 61–64.
43 Fitzsimmons J, Hamoda HM, Swisher T, Terry D, Rosenberger G, Seidman LJ et al.
Diffusion tensor imaging study of the fornix in ﬁrst episode schizophrenia and in
healthy controls. Schizophr Res 2014; 156: 157–160.
44 Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M et al. Mapping the
onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N
Z J Psychiatry 2005; 39: 964–971.
45 Baumann PS, Crespi S, Marion-Veyron R, Solida A, Thonney J, Favrod J et al.
Treatment and early intervention in psychosis program (TIPP-Lausanne): imple-
mentation of an early intervention programme for psychosis in Switzerland. Early
Interv Psychiatry 2013; 7: 322–328.
46 Preisig M, Fenton BT, Matthey ML, Berney A, Ferrero F. Diagnostic interview for
genetic studies (DIGS): inter-rater and test-retest reliability of the French version.
Eur Arch Psychiatry Clin Neurosci 1999; 249: 174–179.
47 Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis
of alcohol use disorders in schizophrenia. Schizophr Bull 1990; 16: 57–67.
48 Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho B-C. Antipsychotic dose
equivalents and dose-years: a standardized method for comparing exposure to
different drugs. Biol Psychiatry 2010; 67: 255–262.
49 Hagmann P, Cammoun L, Gigandet X, Gerhard S, Grant PE, Wedeen V et al. MR
connectomics: principles and challenges. J Neurosci Methods 2010; 194: 34–45.
50 Daducci A, Gerhard S, Griffa A, Lemkaddem A, Cammoun L, Gigandet X et al. The
Connectome Mapper: an open-source processing pipeline to map connectomes
with MRI. PLoS One 2012; 7: e48121.
51 Cammoun L, Gigandet X, Meskaldji D, Philippe J, Sporns O, Do KQ et al. Mapping
the human connectome at multiple scales with diffusion spectrum MRI. J Neurosci
Methods 2012; 203: 386–397.
52 Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C et al. Whole brain
segmentation: automated labeling of neuroanatomical structures in the
human brain. Neuron 2002; 33: 341–355.
53 Wedeen VJ, Hagmann P, Tseng WY, Reese TG, Weisskoff RM. Mapping complex
tissue architecture with diffusion spectrum magnetic resonance imaging. Magn
Reson Med 2005; 54: 1377–1386.
54 Mori S, Crain BJ, Chacko V, Van Zijl P. Three-dimensional tracking of axonal pro-
jections in the brain by magnetic resonance imaging. Ann Neurol 1999; 45:
265–269.
55 Tuch DS. Q-ball imaging. Magn Reson Med 2004; 52: 1358–1372.
56 Wang R, Wedeen VJ. Diffusion Toolkit: a software package for diffusion
imaging data processing and tractography. Proc Intl Soc Mag Reson Med 2007; 15:
3720.
57 Gysin R, Kraftsik R, Boulat O, Bovet P, Conus P, Comte-krieger E et al. Genetic
dysregulation of glutathione synthesis predicts alteration of plasma thiol redox
status in schizophrenia. Antioxid Redox Signal 2011; 15: 2003–2010.
58 Günzler WA, Kremers H, Flohé L. An improved coupled test procedure for glu-
tathione peroxidase (EC 1-11-1-9-) in blood. Z Klin Chem Klin Biochem 1974; 12:
444–448.
59 Baumann PS, Cammoun L, Conus P, Do KQ, Marquet P, Meskaldji D et al. High
b-value diffusion-weighted imaging: a sensitive method to reveal white matter
differences in schizophrenia. Psychiatry Res Neuroimaging 2012; 201: 144–151.
60 Assaf Y, Ben-Bashat D, Chapman J, Peled S, Biton IE, Kafri M et al. High b-value
q-space analyzed diffusion-weighted MRI: application to multiple sclerosis. Magn
Reson Med 2002; 47: 115–126.
61 Mendelsohn A, Strous RD, Bleich M, Assaf Y, Hendler T. Regional axonal
abnormalities in ﬁrst episode schizophrenia: preliminary evidence based on high
b-value diffusion-weighted imaging. Psychiatry Res Neuroimaging 2006; 146:
223–229.
62 Wedeen VJ, Rosene DL, Wang R, Dai G, Mortazavi F, Hagmann P et al. The geo-
metric structure of the brain ﬁber pathways. Science 2012; 335: 1628–1634.
63 Griffa A, Baumann P, Ferrari C, Do K, Conus P, Thiran J et al. Characterizing the
connectome with diffusion spectrum imaging. Hum Brain Mapp 2015; 366:
354–366.
64 Kubicki M, Park H, Westin CF, Nestor PG, Mulkern RV, Maier SE et al. DTI and MTR
abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage
2005; 26: 1109–1118.
65 Kendi M, Kendi ATK, Lehericy S, Ducros M, Lim KO, Ugurbil K et al. Structural and
diffusion tensor imaging of the fornix in childhood- and adolescent-onset schi-
zophrenia. J Am Acad Child Adolesc Psychiatry 2008; 47: 826–832.
66 Brisch R, Bernstein H-G, Stauch R, Dobrowolny H, Krell D, Truebner K et al. The
volumes of the fornix in schizophrenia and affective disorders: a post-
mortem study. Psychiatry Res 2008; 164: 265–273.
67 Zahajszky J, Dickey CC, McCarley RW, Fischer IA, Nestor P, Kikinis R et al. A
quantitative MR measure of the fornix in schizophrenia. Schizophr Res 2001; 47:
87–97.
68 Xin L, Mekle R, Fournier M, Baumann PS, Ferrari C, Alameda L et al. Xin L, Mekle R,
Fournier M, et al. Genetic Polymorphism Associated Prefrontal Glutathione and Its
Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis.
Schizophr Bull 2016 pii: sbw038 (Epub ahead of print).
69 Xin L, Mekle R, Ferrari C, Baumann PS, Alameda L, Moser H et al. GCLC gene
predicts prefrontal glutathione levels: association with peripheral glutathione
peroxidase/glutathione reductaseIn (www.sfn.org) 2015 Neuroscience Meeting
planner, Abstract 282.06.
70 Brigelius-Flohé R, Maiorino M. Glutathione peroxidases. Biochim Biophys Acta
2013; 1830: 3289–3303.
71 Namani A, Li Y, Wang XJ, Tang X. Modulation of NRF2 signaling pathway by
nuclear receptors: implications for cancer. Biochim Biophys Acta 2014; 1843:
1875–1885.
72 Miyamoto Y, Koh YH, Park YS, Fujiwara N, Sakiyama H, Misonou Y et al. Oxidative
stress caused by inactivation of glutathione peroxidase and adaptive responses.
Biol Chem 2003; 384: 567–574.
73 Buckman TD, Kling AS, Eiduson S, Sutphin MS, Steinberg A. Glutathione perox-
idase and CT scan abnormalities in schizophrenia. Biol Psychiatry 1987; 22:
1349–1356.
74 Harrison PJ. The hippocampus in schizophrenia: a review of the neuropatholo-
gical evidence and its pathophysiological implications. Psychopharmacology (Berl)
2004; 174: 151–162.
75 Mondelli V, Cattaneo A, Murri MB, Forti M, Di, Handley R, Hepgul N et al. Stress
and inﬂammation reduce brain-derived neurotrophic factor expression in ﬁrst-
episode psychosis: a pathway to smaller hippocampal volume. J Clin Psychiatry
2011; 72: 1677–1684.
GPx and fornix–hippocampus circuit in psychosis
PS Baumann et al
7
Translational Psychiatry (2016), 1 – 8
76 Liu T, Lu Q-B, Yan L, Guo J, Feng F, Qiu J et al. Comparative study on serum levels
of 10 trace elements in schizophrenia. PLoS One 2015; 10: e0133622.
77 Bernstein H-G, Krause S, Krell D, Dobrowolny H, Wolter M, Stauch R et al. Strongly
reduced number of parvalbumin-immunoreactive projection neurons in the
mammillary bodies in schizophrenia: further evidence for limbic neuropathology.
Ann N Y Acad Sci 2007; 1096: 120–127.
78 Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M. Neuroscience
and biobehavioral reviews mitochondrial dysfunction in schizophrenia:
pathways, mechanisms and implications. Neurosci Biobehav Rev 2015; 48:
10–21.
79 Robicsek O, Karry R, Petit I, Salman-Kesner N, Müller F-J, Klein E et al. Abnormal
neuronal differentiation and mitochondrial dysfunction in hair follicle-derived
induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry 2013; 18:
1067–1076.
80 Rosenfeld M, Brenner-lavie H, Ari SG, Kavushansky A, Ben-Shachar D. Perturbation
in mitochondrial network dynamics and in complex I dependent cellular
respiration in schizophrenia. Biol Psychiatry 2011; 69: 980–988.
81 Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang J, Grifﬁn JL et al. Mito-
chondrial dysfunction in schizophrenia : evidence for compromised brain meta-
bolism and oxidative stress. Mol Psychiatry 2004; 9: 684–697.
82 Grignon S, Chianetta JM. Assessment of malondialdehyde levels in schizophrenia:
a meta-analysis and some methodological considerations. Prog Neuro-
Psychopharmacol Biol Psychiatry 2007; 31: 365–369.
83 Kubicki M, Shenton ME. Diffusion tensor imaging ﬁndings and their implications
in schizophrenia. Curr Opin Psychiatry 2014; 27: 179–184.
84 Alameda L, Ferrari C, Baumann PS, Gholam-Razaee M, Do KQ, Conus P. Childhood
sexual and physical abuse: age at exposure modulates impact on functional
outcome in early psychosis patients. Psychol Med 2015, 45: 2727–2736.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons
license, users will need to obtain permission from the license holder to reproduce the
material. To view a copy of this license, visit http://creativecommons.org/licenses/
by/4.0/
© The Author(s) 2016
Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)
GPx and fornix–hippocampus circuit in psychosis
PS Baumann et al
8
Translational Psychiatry (2016), 1 – 8
